16
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Induction of Complete Haematological Remission After Monotherapy with AntLCD20 Monoclonal Antibody (RITUXIMAB) in a Patient with Alkylating Agent Resistant Waldenstrom's Macroglobulinaemia

, &
Pages 203-206 | Received 01 May 1999, Published online: 01 Jul 2009

References

  • MacKenzie M. R., Fudenberg H. H. Macroglobu-linemia An analysis of forty patients. Blood 1972; 39: 874–889
  • Kyle R. A., Garton J. P. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 1987; 62: 719–731
  • Kucharska-Pulczynska M., Ellegaard J., Hokland P. Analysis of leucocyte differentiation antigens in blood and marrow from patients with Waldenstrom's macro-globulinemia. Br J Haematol 1987; 65: 395–399
  • Dimopoulos M. A., Alexanian R. Waldenstrom's macroglobulinemia. Blood 1994; 83: 1452–1459
  • Obrien S., Kantarjian H. M., Keating M. J. Purine analogues in chronic lymphocytic leukemia and Waldenstrom's macroglobulinemia. Ann Oncol 1996; 7(suppl 6)27–33
  • Maloney D. G., Liles T. M., Czenvinski D. K., Waldichuk C., Rosenberg J., Grillo-Lopez A., Levy R. Phase I clinical trial using escalating single-dose infusion of chi-meric anti-CD20 monoclonal antibody (IDEC-c2b8) in patients with recurrent B-cell lymphoma. Blood 1994; 84: 2457–2466
  • Reff M. E., Carner K., Chambers K. S., Chinn P. C., Leonard J. E., Raab R., Newman R. A., Hanna N., Anderson D. R. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994; 83: 435–445
  • McLaughlin P., Cabanillas F., Grillo-Lopez A. J., Link B. K., Levy R., Czuczman M., Heyman M. R., Williams M., Jain V., Bence-Bruckler I., Ho A. D., Lister J., Rosenberg J., Dallaire B. K., Shen D. IDEC-C2B8 anti-CDZO antibody Final report on a phase III pivotal trial in patients with relapsed low grade or follicular lymphoma. Blood 1996; 88: 90a, (abstr. suppl 1).
  • Coiffier B., Haioun C., Ketterer N., Engert A., Tilly H., Ma D., Johnson P., Lister A., Feuring-Buske M., Radford J. A., Capdeville R., Diehl V., Reyes F. Rituximab (AntiCD 20 monoclonal Antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter Phase II study. Blood 1998; 92: 1927–1932
  • Byrd J. C., White C. A., Link B., Thomas S., Valasquez W. S., Rosenberg J., Grillo-Lopez A. J. Rituximab therapy in previously treated Waldenström's macroglobuline-mia: Preliminary evidence of activity. Blood 1998; 92: 433a, (abstr. suppl 1).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.